Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,275,290 papers from all fields of science
Search
Sign In
Create Free Account
Disease Progression
Known as:
Course of disorder
, Progression, Disease
, Progressions, Disease
Expand
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Narrower (6)
Acute Disease
Cancer Progression
Chronic disease
Sequela of disorder
Expand
Forecast of outcome
Pathologic Processes
Progressive Disease
Progressive Neoplastic Disease
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Heshui Shi
,
Xiaoyu Han
,
+5 authors
C. Zheng
Lancet. Infectious Diseases (Print)
2020
Corpus ID: 211554997
Highly Cited
2017
Highly Cited
2017
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
P. Lampertico
,
K. Agarwal
,
+5 authors
F. Tacke
Journal of Hepatology
2017
Corpus ID: 13700818
Review
2015
Review
2015
Neuroinflammation in Alzheimer's disease
M. Heneka
,
M. Carson
,
+39 authors
M. Kummer
Lancet Neurology
2015
Corpus ID: 4705464
Review
2012
Review
2012
Chronic kidney disease
A. Levey
,
J. Coresh
The Lancet
2012
Corpus ID: 3297665
Highly Cited
2012
Highly Cited
2012
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
S. Topalian
,
F. Hodi
,
+27 authors
M. Sznol
New England Journal of Medicine
2012
Corpus ID: 1358630
BACKGROUND Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We…
Expand
Highly Cited
2011
Highly Cited
2011
American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management
G. Raghu
,
H. Collard
,
+31 authors
H. Schünemann
2011
Corpus ID: 13448600
Ganesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr, Kevin K. Brown, Thomas V. Colby, Jean-Franc…
Expand
Highly Cited
2011
Highly Cited
2011
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase…
Caicun Zhou
,
Yi-long Wu
,
+20 authors
C. You
The Lancet Oncology
2011
Corpus ID: 11704864
Review
2009
Review
2009
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E. Eisenhauer
,
P. Therasse
,
+13 authors
J. Verweij
European Journal of Cancer
2009
Corpus ID: 8748071
Highly Cited
1996
Highly Cited
1996
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
Rong Liu
,
W. Paxton
,
+7 authors
N. Landau
Cell
1996
Corpus ID: 16965624
Highly Cited
1996
Highly Cited
1996
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Yaoxing Huang
,
W. Paxton
,
+14 authors
R. Koup
Nature Network Boston
1996
Corpus ID: 41120337
A 32–nucleotide deletion (δ32) within the β–chemokine receptor 5 (CCR5) gene has been described in subjects who remain uninfected…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE